Rajiv Agarwal United States

• Effect of a 12-week Intradialytic Cycling Intervention on Hemodialysis-induced Myocardial Stunning: A Multi-centre Randomized Controlled Trial
  ClaraBohm Speaker Canada
• TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes
  JosephineChow Speaker Australia
• Effect of Finerenone on Circulating Biomarkers: A CONFIDENCE Analysis
  MarioBerger Speaker mario.berger@bayer.comGermany
• Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-creatinine Ratio by Age and Sex in the CONFIDENCE Trial
  RajivAgarwal Speaker United States
• Estimated Glomerular Filtration Rate, Systolic Blood Pressure, and Urinary Albumin-to-creatinine Ratio — Unravelling the Interplay in Combination: Findings From the CONFIDENCE Trial
  RajivAgarwal Speaker United States
• Lowering-Hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double Blind Randomized Controlled Trial
  Naya Huang Speaker huangnaya@163.comChina

• Welcome & Introduction
  NaokiSato Speaker nms-ns@nms.ac.jpJapan
• Early Action, Stronger Protection
  BrendonNeuen Speaker Australia
• Lower UACR, Optimized Outcomes
  RajivAgarwal Speaker United States
• Finerenone, a CKM Pillar
  Jozineter Maaten Speaker Netherlands
• Changing Trajectories in Practice
  KeizoKanasaki Speaker kkanasakidr@gmail.comJapan
• Q&A and Closing Remarks / Panel Discussion
  NaokiSato Speaker nms-ns@nms.ac.jpJapan

  RajivAgarwal Speaker United States

• The Pillar Perspective: A Deep Dive Into Clinical Evidence
  RajivAgarwal Speaker United States
• Panel Discussion
  Multimodal Management of CKD and HF
  RajivAgarwal Moderator United States

  Jozineter Maaten Panel Netherlands

  NaokiSato Panel nms-ns@nms.ac.jpJapan